| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/11/2011 | CN102048977A Chinese medicinal composition for treating chronic myeloid leukemia |
| 05/11/2011 | CN102048976A Traditional Chinese medicine composition for treating acute myeloblastic leukemia (AML) M1 |
| 05/11/2011 | CN102048956A Medicinal liquor |
| 05/11/2011 | CN102048950A Nourishing and strengthening health wine and preparation method thereof |
| 05/11/2011 | CN102048858A Medicine composition for treating cirrhosis, hepatic ascites and liver cancer |
| 05/11/2011 | CN102048827A Application of shiandra for preparing medicaments for resisting tumor invasion and metastasis |
| 05/11/2011 | CN102048806A Composition for protection and treatment of gastroenteropathy and digestive system cancer and preparation method thereof |
| 05/11/2011 | CN102048805A Chinese medicinal preparation for treating malignant tumor and preparation method thereof |
| 05/11/2011 | CN102048801A Chinese medicinal preparation for treating acute and chronic myeloid leukemia |
| 05/11/2011 | CN102048794A Isatis root oral liquid and preparation method thereof |
| 05/11/2011 | CN102048791A Method for preparing sinigrin extract |
| 05/11/2011 | CN102048754A Compound arsenic acid preparation capable of reducing toxicity of arsenic |
| 05/11/2011 | CN102048743A Medical combination for treating complications of multiple myeloma |
| 05/11/2011 | CN102048737A Pharmaceutical composition for treating tumor diseases |
| 05/11/2011 | CN102048736A Dasatinib pharmaceutical composition and preparation method thereof |
| 05/11/2011 | CN102048727A Application of formononetin in preparing of medicament for restricting angiogenesis |
| 05/11/2011 | CN102048723A Acid containing oxaliplatin formulations |
| 05/11/2011 | CN102048700A Colon targeted preparation of semi-pinnated brake herb extract 5F and preparation method thereof |
| 05/11/2011 | CN102048699A Preparation method for sustained release microsphere of injection triptorelin acetate |
| 05/11/2011 | CN102048697A Method for preparing solid lipid nanoparticles of water-soluble anti-tumor medicine |
| 05/11/2011 | CN102048695A Preparation method of protein nanoparticle for in vivo delivery of pharmacologically active agent |
| 05/11/2011 | CN102048694A Polypeptide-modified liver tumor-targeted nano medicine delivery system and preparation method thereof |
| 05/11/2011 | CN102048693A Liposome having internal aqueous phases of benzenesulfonic acid derivatives |
| 05/11/2011 | CN102048688A Taxol submicroemulsion taking cholesterol complex as intermediate carrier |
| 05/11/2011 | CN102048683A Lentinan injection and preparation method thereof |
| 05/11/2011 | CN102048681A Mifepristone slow release preparation characterized by gastric stasis and preparation method thereof |
| 05/11/2011 | CN101732535B Chinese medicinal preparation for treating cervical cancer |
| 05/11/2011 | CN101716175B New application of 3-amido-6-(4-methoxyphenyl) thiopheno[2, 3-b] pyridine-2-formamide |
| 05/11/2011 | CN101703514B Application of sophorolipids in preparation of medicament for resisting cervical cancer |
| 05/11/2011 | CN101700386B Traditional Chinese medicine composition resistant to liver cancer and medicine coat thereof |
| 05/11/2011 | CN101664512B Method for preparing traditional Chinese medicine preparation containing herba sarcandrae extracts |
| 05/11/2011 | CN101648959B Coumaronochromones compound and preparation and application thereof |
| 05/11/2011 | CN101648934B Isopentenyl flavone and application thereof |
| 05/11/2011 | CN101638656B Blood serum/blood plasma miRNA marker related to non-small cell lung cancer (SCLC) prognosis and application thereof |
| 05/11/2011 | CN101619315B Functional gene Rdr-lec sequence of rana chensinensis lectin sample, construction method, amino acid sequence thereof and application thereof |
| 05/11/2011 | CN101606907B Fotemustine solid lipid nanoparticle and preparation method thereof |
| 05/11/2011 | CN101597612B SEC2 mutant gene with increased activity of super-antigen and preparation method thereof |
| 05/11/2011 | CN101503459B Bloody noun antibacterial peptide temporin-Lb, genes thereof and use in pharmacy |
| 05/11/2011 | CN101503423B Parachlorobenzoyl hydrazone organotin complex, preparation and use |
| 05/11/2011 | CN101485694B Method for extracting Ganoderma lucidum triterpenes components |
| 05/11/2011 | CN101439025B Silymarin high-efficient long-acting preparation and production method thereof |
| 05/11/2011 | CN101434622B Antimony triphenyl complexes, as well as preparation method and application thereof |
| 05/11/2011 | CN101428033B Mix-configuration ginsenoside Rh2 and uses thereof |
| 05/11/2011 | CN101412743B Preparation of 2 alpha-hydroxy-substituted white birch keto acid |
| 05/11/2011 | CN101412726B Novel heterocyclic compounds |
| 05/11/2011 | CN101402650B Organotin coordination compound, preparation and uses thereof |
| 05/11/2011 | CN101381404B Targeting tumor protein KCT-W2, preparation method and application |
| 05/11/2011 | CN101381380B Platinum (II) complexes and antineoplastic activity thereof |
| 05/11/2011 | CN101361969B Therapeutic hepatitis b vaccine and preparation method and use thereof |
| 05/11/2011 | CN101353647B Simulating retrovirus of target tumor, and preparation and use thereof |
| 05/11/2011 | CN101306027B Extracting method of medical mangrove acanthus total flavonoids |
| 05/11/2011 | CN101298482B Dextran |
| 05/11/2011 | CN101280318B Recombinant human HNP gene liposome complex, preparation and use thereof |
| 05/11/2011 | CN101255103B Preparation method of marine penicillium antitumor reactive compound and utilization thereof |
| 05/11/2011 | CN101250188B Technique for preparing willow leaf tabersonine |
| 05/11/2011 | CN101235060B Isograndidentatin, preparation method thereof and application of the same in preparing antineoplastic medicament |
| 05/11/2011 | CN101212983B A vaccine composition comprising alpha-galactosylceramide as an adjuvant for intranasal administration |
| 05/11/2011 | CN101167778B Semen vaccariae extraction for inhibiting angiogenesis and preparation and application thereof |
| 05/11/2011 | CN101157717B Preparation method of Ardisia mamillata B and uses thereof |
| 05/11/2011 | CN101152408B Pharmaceutical composition having function of resistance to cancer of the lungs |
| 05/11/2011 | CN101121743B Process for extracting anticancer product from natural plant |
| 05/11/2011 | CN101116745B Human papilloma virus sample particle vaccines |
| 05/11/2011 | CN101104864B Method for preparing epothilones B |
| 05/11/2011 | CN101081315B Method for forming medical devices containing rapamycin analogs |
| 05/11/2011 | CN101050179B 2,3,4,5-tetrasubstituted derivatives of benzyl ethylene class, preparation method and application |
| 05/11/2011 | CN101027302B Pyrrolo-pyridine kinase modulators |
| 05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7939654 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 05/10/2011 | US7939650 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer |
| 05/10/2011 | US7939646 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/10/2011 | US7939639 Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology |
| 05/10/2011 | US7939625 Somatostatin analogues |
| 05/10/2011 | US7939532 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 05/10/2011 | US7939525 Conjugated psychotropic drugs and uses thereof |
| 05/10/2011 | US7939292 Modified heparinase III and methods of sequencing therewith |
| 05/10/2011 | US7939268 Compositions and methods for the diagnosis and treatment of tumor |
| 05/10/2011 | US7939109 Method of treating neoplastic disease in a human or animal patient |
| 05/10/2011 | US7939082 Papilloma virus vaccine |
| 05/10/2011 | US7939080 HER-2 binding antagonists |
| 05/10/2011 | US7939077 DNA sequences that code antibodies or fragments; genetic vectors and host cells transformed by the vector, used for diagnosis and prophylaxis of cancer |
| 05/10/2011 | US7939074 Combination of an anti-EP-CAM antibody with a chemotherapeutic agent |
| 05/10/2011 | US7939073 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 05/10/2011 | US7939071 Artery- and vein-specific proteins and uses therefor |
| 05/10/2011 | US7939061 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 05/10/2011 | US7938641 Extrusion die |
| 05/10/2011 | CA2718460A1 Compositions for intratumoral administration |
| 05/10/2011 | CA2622805C Compressed tablets comprising valsartan |
| 05/10/2011 | CA2566436C Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis |
| 05/10/2011 | CA2565850C Tetrahydrocarbazole derivatives with biological action and solubility as ligands for g-protein coupled receptors (gpcrs) |
| 05/10/2011 | CA2501322C Quinolinyl-pyrrolopyrazoles |
| 05/10/2011 | CA2487388C Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments |
| 05/10/2011 | CA2480033C In vivo use of glutathionone s-transferase activated nitric oxide donors |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2475498C Piperidine derivative and pharmaceutical composition comprising the same as active ingredient |
| 05/10/2011 | CA2473572C Quinazoline compounds |
| 05/10/2011 | CA2460436C Stabilization of active agents by formulation into nanoparticulate form |
| 05/10/2011 | CA2437535C Polynucleotide useful for modulating cancer cell proliferation |
| 05/10/2011 | CA2431890C Lipid microparticles by cryogenic micronization |
| 05/10/2011 | CA2423524C Topical anti-cancer compositions and methods of use thereof |
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |